EVENTS

Frost & Sullivan × Shanghai University of Finance and Economics | Industry Research Empowering Chief Investment Officer Course Successfully Completed
Explore more
Frost & Sullivan senior executives attend the High-Quality Development Conference on New Quality Productivity Empowering the Food Industry, interpreting the five major trends in innovation in new consumer categories, and exploring the new drivers for high-quality development in the food industry.
Explore more
Event Preview | The Pujiang Innovation Forum · The 2026 Brain-Computer Interface Conference Investment and Financing Sub-forum will be held in Shanghai on November 27
Explore more
Countdown: 4 Days Left | The 2026 New Consumer Brand Transformation and Growth Conference will be held in Beijing on October 23
Explore more
Frost & Sullivan executives were invited to attend Look·Entrepreneur AI Lecture: From delivery to operation, the commercialization of humanoid robots relies on 'double closed loop' strategy
Explore more
Event Preview | Frost & Sullivan Will Attend CBB 2026 Forum to Decode the Future of Liquid Foods
Explore more
The registration process for the third Forbes China Industry Development Leaders Award is ongoing.
Explore more
Frost & Sullivan Invites You to Attend | China Enterprises Globalization Industry Cooperation Conference
Explore more
Frost & Sullivan, as a recommended enterprise for the Hong Kong Pavilion, appeared at the 5th Global Digital Trade Expo.
Explore more
Wang Chenhui, Managing Partner and President of Frost & Sullivan China, was invited to attend the 2026 Yunqi Conference and deliver a keynote speech
Explore more
Frost & Sullivan was invited to attend the 2026 Shanghai Rare Diseases Public Welfare Care and Innovation Development Exchange Meeting, sharing the strategic value of rare disease innovation and China's development opportunities
Explore more
Frost & Sullivan was invited to attend the 2026 Greater Bay Area ADC and Antibody Drug Development Forum to share the current investment and financing landscape and future trends in the global antibody and conjugate drug industry.
Explore more
